Abstract
Hyperthyroidism is an uncommon cause of hypercalcemia (HYPERCA). There is little information to guide the clinician on calcium (CA) response in relation to thyroid hormone control. This knowledge may be important when HYPERCA needs to be quickly treated due to its severity or to underlying patient co-morbidities. We describe a patient with HYPERCA of moderate severity due to Graves’ disease (GD) hyperthyroidism in whom normalization of CA level was a priority. Changes in CA levels in response to improvement in thyroid function and the role of anti-resorptive agents in this setting are discussed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
